Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MuGard for Stomatitis Prevention in Everolimus-Treated Breast Cancer
NCT02015559Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2014
- Primary completion
- Nov 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of MuGard in stomatitis, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Oct 2014; status: completed.
02
Drugs
MuGard
03
Conditions
stomatitis
Beyond the preview
Go deeper on NCT02015559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015559.